Team

Michael Weisser

Chief Executive Officer

Michael Weisser is CEO of AiM. He holds a Master’s equivalent in Economics from the Albert Ludwig University of Freiburg. Mr. Weisser has been working at AiM since 2009, providing consultancy to industry. His field of work comprises reimbursement, market access and HTA of diagnostic and therapeutic procedures which are based on the use of medical devices, especially in the German, Swiss and Austrian markets. He also plans and holds international workshops.

Kirsten Sellen

Consultant

Kirsten Sellen is a consultant at AiM. She holds a Master of Science equivalent in Biology from the university of Tübingen. She is responsible for systematic reviews, evaluation of scientific publications, as well as for market access research with subsequent preparation of reimbursement dossiers for medical device technologies. Prior to joining AiM, she has worked for over 15 years as Clinical Research Associate and Data Manager in the pharmaceutical and medical device industries.

Patricia Heinl

Research Analyst

Patricia Heinl, PhD, Research Analyst, holds a Bachelor and Master degree in biomedical chemistry from the University of Mainz. Her PhD project involved preclinical studies of immunological disorders and cell-based therapies, making her a specialist in medical scientific innovations. At AiM, she is responsible for systematic literature research and evidence assessment, such as the compilation of value dossiers and reimbursement applications for medical devices in the context of German market access.